Literature DB >> 16958680

Transcriptional regulation of stellate cell activation.

Scott L Friedman1.   

Abstract

The identification of activated hepatic stellate cells and related cell types as key fibrogenic effectors during liver injury has led to intense evaluation of transcriptional events underlying their behavior. While initial studies focused on characterizing interactions between transcription factors and regulatory regions within gene promoters, epigenetic mechanisms have emerged as major determinants of gene activation and repression, in particular histone acetylation and promoter methylation, as well as other complex conditional interactions that underlie global changes in gene expression. Three examples are provided that illustrate how stellate cell activation may be controlled by widely divergent regulatory pathways, including alternative splicing of a growth inhibitory transcription factor (Kruppel-like factor-6), epigenetic regulation of a factor regulating stellate cell survival (nuclear factor kappaB), and regulation of a transcription factor whose expression maintains stellate cell quiescence (LIM homeobox gene 2 [Lhx2]). These complex cascades illustrate how clarifying the finely tuned interdependent layers of transcriptional, translational, post-translational and epigenetic gene regulation in stellate cells is raising new prospects for therapy of hepatic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16958680     DOI: 10.1111/j.1440-1746.2006.04585.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  13 in total

1.  Preproendothelin-1 expression is negatively regulated by IFNγ during hepatic stellate cell activation.

Authors:  Tianxia Li; Zengdun Shi; Don C Rockey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-02-02       Impact factor: 4.052

Review 2.  Tales from the crypts: regulatory peptides and cytokines in gastrointestinal homeostasis and disease.

Authors:  Juanita L Merchant
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 3.  Angiogenesis and liver fibrosis.

Authors:  Gülsüm Özlem Elpek
Journal:  World J Hepatol       Date:  2015-03-27

4.  p53-Inducible DHRS3 is an endoplasmic reticulum protein associated with lipid droplet accumulation.

Authors:  Chad Deisenroth; Yoko Itahana; Laura Tollini; Aiwen Jin; Yanping Zhang
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

5.  Influence of olive and rosemary leaves extracts on chemically induced liver cirrhosis in male rats.

Authors:  Atef M Al-Attar; Nessreen A Shawush
Journal:  Saudi J Biol Sci       Date:  2014-09-17       Impact factor: 4.219

Review 6.  Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis?

Authors:  Ningling Kang; Vijay H Shah; Raul Urrutia
Journal:  Mol Cancer Res       Date:  2014-12-29       Impact factor: 5.852

7.  Pathophysiological characteristics of dimethylnitrosamine-induced liver fibrosis in acute and chronic injury models: a possible contribution of KLF5 to fibrogenic responses.

Authors:  Fumihiro Ohara; Aisuke Nii; Yojiro Sakiyama; Megumi Tsuchiya; Shinji Ogawa
Journal:  Dig Dis Sci       Date:  2007-12-20       Impact factor: 3.199

Review 8.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

Review 9.  Organotypic liver culture models: meeting current challenges in toxicity testing.

Authors:  Edward L LeCluyse; Rafal P Witek; Melvin E Andersen; Mark J Powers
Journal:  Crit Rev Toxicol       Date:  2012-05-15       Impact factor: 5.635

10.  Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells.

Authors:  Nathan J Bowen; L DeEtte Walker; Lilya V Matyunina; Sanjay Logani; Kimberly A Totten; Benedict B Benigno; John F McDonald
Journal:  BMC Med Genomics       Date:  2009-12-29       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.